PNEUMONIA
Some Selected Abstracts: | |
1. |
Kleckner M 3rd. Blending hospital economics with quality of
care: a case study. Healthc Financ Manage. 2004 Dec;58(12):64-8, 70. La Costa Group, LLC, Carlsbad, Calif., USA. martin@lacostagroup.com Many
hospitals have attained substantial gains in cost control. Unfortunately,
the impact of cost initiatives on quality of care and clinical outcomes is
not clear. However, by looking at the patient management costs incurred
relative to clinical outcomes as the patient progresses through diagnosis
and treatment, healthcare organizations can evaluate a technology's
economic value. |
2. |
Hui DS, Wong KT, Antonio GE, Lee N, Wu A, Wong V, Lau W, Wu
JC, Tam LS, Yu LM, Joynt GM, Chung SS, Ahuja AT, Sung JJ. Severe acute
respiratory syndrome: correlation between clinical outcome and radiologic
features. Radiology. 2004 Nov;233(2):579-85. Department
of Diagnostic Radiology and Organ Imaging, The Chinese Univ of Hong Kong,
Prince of Wales Hosp, 30-32 Ngan Shing St, Shatin, Hong Kong SAR. PURPOSE:
To evaluate whether there is a correlation between the clinical outcomes
and radiologic features of severe acute respiratory syndrome (SARS).
MATERIALS AND METHODS: The clinical, laboratory, and radiologic features
of 138 patients with SARS were analyzed. Three radiologists in consensus
retrospectively assessed the frontal chest radiographs obtained at
presentation and during treatment (n = 2045) for the distribution (each
lung was divided into upper, middle, and lower zones) and extent of lung
parenchymal abnormality. Clinical end points included intensive care unit
(ICU) admission and death. RESULTS: Thirty-six (26.1%) patients required
ICU care, and eight (5.8%) died. The patients who required ICU care and/or
died had more extensive consolidation on chest radiographs obtained
initially (median percentage of consolidation, 3.30%, with interquartile
range [IR] of 1.70%-8.78% vs 1.70% [IR, 0%-3.30%]; P < .001) and on day
7 after fever onset (median percentage of consolidation, 15.00% [IR,
6.48%-28.73%] vs 5.00% [IR, 2.50%-7.50%]; P < .001) than did surviving
patients who did not require ICU care. Patients with involvement of more
than one lung zone on initial and day 7 chest radiographs were more likely
to require ICU care and/or die than were those with involvement of one or
fewer zones (P < .001). Patients with bilateral pneumonic changes at
presentation were more likely to have an adverse outcome than were those
with unilateral pneumonia (P < .001). Involvement of more than one lung
zone at baseline chest radiography was an independent predictor of ICU
admission and/or death (odds ratio, 3.16; 95% confidence interval: 1.07,
9.32; P = .037) after adjustments for other significant factors (ie,
patient age, and baseline neutrophil count and lactate dehydrogenase
level). CONCLUSION: More extensive airspace disease at presentation is an
independent predictor of adverse outcome in patients with SARS. |
3. |
Bissinger R, Carlson C, Hulsey T, Eicher D. Secondary
surfactant deficiency in neonates. J Perinatol. 2004 Oct;24(10):663-6. College of Nursing, Medical University of South Carolina, SC 29445, USA. Surfactant
treatment has become the standard of care in premature infants with
respiratory distress syndrome (RDS). Pulmonary hemorrhage, pulmonary
edema, pneumonia, and atelectasis have been shown to liberate inflammatory
mediators and plasma proteins, which damage type II pneumocytes and
inactivate surfactant. These disease processes may, therefore, lead to a
secondary surfactant inactivation or deficiency, which can be an
unrecognized cause of respiratory decompensation after initial recovery
from RDS in this vulnerable population. This is a descriptive report of
three cases, which had acute respiratory decompensation between 1 and 3
weeks of age. All three infants demonstrated a response to secondary doses
of surfactant. We submit that the diagnosis and treatment of secondary
surfactant deficiency in the critically ill premature neonate warrants
further study. |
Diagnosis,
Diagnostics, Immunodiagnosis & Immunodiagnostics: |
11702.
Alvarez-Lerma
F, Torres A. Severe community-acquired pneumonia. Curr Opin Crit Care.
2004 Oct;10(5):369-74. Review. 11703.
Astudillo
L, Martin-Blondel G, Sans N, Dhaste G, Couret B, Arlet-Suau E. Solitary
nodular form of bronchiolitis obliterans organizing pneumonia. Am J Med.
2004 Dec 1;117(11):887-8. 11704.
Bach
JR. Don't forget the abdominal thrust.Chest. 2004 Oct;126(4):1388-9; 11705.
Bandi
VD, Munnur U, Matthay MA. Acute lung injury and acute respiratory
distress syndrome in pregnancy. Crit Care Clin. 2004 Oct;20(4):577-607.
Review. 11706.
Bissinger
R, Carlson C, Hulsey T, Eicher D. Secondary surfactant deficiency in
neonates. J Perinatol. 2004 Oct;24(10):663-6. 11707.
Carver
RT, Boysel LC, Marciniak CM, Nussbaum SB. Myotonic dystrophy presenting
as new-onset hand weakness and recurrent pneumonia in a patient with
paraplegia: a case report. Arch Phys Med Rehabil. 2004
Nov;85(11):1896-8. 11708.
Cetinkaya
F, Gogremis A, Kutluk G. Comparison of two antibiotic regimens in the
empirical treatment of severe childhood pneumonia. Indian J Pediatr.
2004 Nov;71(11):969-72. 11709.
Charles
PG, Ananda-Rajah M, Johnson PD, Grayson ML. Are the Australian
guidelines asking too much of the Pneumonia Severity Index (PSI)? Med J
Aust. 2004 Nov 1;181(9):515; 11710.
Chen
HL, Chiou SS, Hsiao HP, Ke GM, Lin YC, Lin KH, Jong YJ. Respiratory
adenoviral infections in children: a study of hospitalized cases in
southern Taiwan in 2001--2002. J Trop Pediatr. 2004 Oct;50(5):279-84. 11711.
Crowe
JE Jr. Human metapneumovirus as a major cause of human respiratory tract
disease. Pediatr Infect Dis J. 2004 Nov;23(11 Suppl):S215-21. Review. 11712.
Davies
G, Wells AU, du Bois RM. Respiratory bronchiolitis associated with
interstitial lung disease and desquamative interstitial pneumonia. Clin
Chest Med. 2004 Dec;25(4):717-26, vi. Review. 11713.
Demetriades
D, Constantinou C, Salim A, Velmahos G, Rhee P, Chan L. Liver cirrhosis
in patients undergoing laparotomy for trauma: effect on outcomes. J Am
Coll Surg. 2004 Oct;199(4):538-42. 11714.
Flaherty
KR, Martinez FJ. Cigarette smoking in interstitial lung disease:
concepts for the internist. Med Clin North Am. 2004 Nov;88(6):1643-53,
xiii. Review. 11715.
Gea-Banacloche
JC, Opal SM, Jorgensen J, Carcillo JA, Sepkowitz KA, Cordonnier C.
Sepsis associated with immunosuppressive medications: an
evidence-based review. Crit Care Med. 2004 Nov;32(11 Suppl):S578-90.
Review. 11716.
Gesell
SB, Wolosin RJ. Inpatients' ratings of care in 5 common clinical
conditions. Qual Manag Health Care. 2004 Oct-Dec;13(4):222-7. 11717.
Hui
DS, Wong KT, Antonio GE, Lee N, Wu A, Wong V, Lau W, Wu JC, Tam LS, Yu
LM, Joynt GM, Chung SS, Ahuja AT, Sung JJ. Severe acute respiratory
syndrome: correlation between clinical outcome and radiologic features.
Radiology. 2004 Nov;233(2):579-85. 11718.
Kaira
K, Takise A, Goto T, Horie T, Mori M. Barium sulphate aspiration.
Lancet. 2004 Dec 18;364(9452):2220. 11719.
Kleckner
M 3rd. Blending hospital economics with quality of care: a case study.
Healthc Financ Manage. 2004 Dec;58(12):64-8, 70. 11720.
Lim
WS. Identifying failure of empirical treatment for pneumonia: vigilance
and common sense. Thorax. 2004 Nov;59(11):918-9. 11721.
Marrie
TJ, Beecroft MD, Herman-Gnjidic Z. Resolution of symptoms in patients
with community-acquired pneumonia treated on an ambulatory basis. J
Infect. 2004 Nov;49(4):302-9. 11722.
Narita
M, Tanaka H. Two distinct patterns of pleural effusions caused by
Mycoplasma pneumoniae infection. Pediatr Infect Dis J. 2004
Nov;23(11):1069; 11723.
Poon
LL, Guan Y, Nicholls JM, Yuen KY, Peiris JS. The aetiology, origins, and
diagnosis of severe acute respiratory syndrome. Lancet Infect Dis. 2004
Nov;4(11):663-71. Review. 11724.
van
Saene HK, Ashworth M, Petros AJ, Sanchez M, de la Cal MA. Do not suction
above the cuff. Crit Care Med. 2004 Oct;32(10):2160-2. 11725.
Williamson
JP, Illing R, Gertler P, Braude S. Near-drowning treated with
therapeutic hypothermia. Med J Aust. 2004 Nov 1;181(9):500-1. 11726.
Yiannakoulias
N, Russell ML, Svenson LW, Schopflocher DP. Doctors, patients and
influenza-like illness: clinicians or patients at risk? Public Health.
2004 Oct;118(7):527-31. |
Pathogenesis: |
11727.
Reinert
RR. Pneumococcal conjugate vaccines--a European perspective. Int J Med
Microbiol. 2004 Oct;294(5):277-94. Review. 11728.
Remick
DG. Do not get sick when you are sick: the impact of comorbid
conditions. Crit Care Med. 2004 Oct;32(10):2147-8. |
Vaccines: |
11729.
Fletcher
MA, Fabre P, Debois H, Saliou P. Vaccines administered simultaneously:
directions for new combination vaccines based on an historical review of
the literature. Int J Infect Dis. 2004 Nov;8(6):328-38. |
Therapy: |
11730.
Barthwal
MS, Deoskar RB, Rajan KE, Chatterjee RS. Intrapleural streptokinase in
complicated parapneumonic effusions and empyema. Indian J Chest Dis
Allied Sci. 2004 Oct-Dec;46(4):257-61. 11731.
Mouw
DR, Langlois JP, Turner LF, Neher JO. Clinical inquiries. Are
antibiotics effective in preventing pneumonia for nursing home patients?
J Fam Pract. 2004 Dec;53(12):994-6. Review. 11732.
Peterson
MW, Hornick DB. Community-acquired pneumonia guidelines: Peering back
through the looking glass...clearly? Am J Med. 2004 Nov
15;117(10):799-800. |